Herantis Financial Statements From 2010 to 2026
Herantis Pharma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Herantis Pharma's valuation are provided below:Herantis Pharma Oyj does not presently have any fundamental trends for analysis.
This module can also supplement various Herantis Pharma Technical models . Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Check Herantis Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Herantis Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Herantis financial statements analysis is a perfect complement when working with Herantis Pharma Valuation or Volatility modules.
Herantis |
Herantis Pharma Oyj Company Current Valuation Analysis
Herantis Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Herantis Pharma Current Valuation | 27.19 M |
Most of Herantis Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Herantis Pharma Oyj is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Herantis Pharma Oyj has a Current Valuation of 27.19 M. This is 99.81% lower than that of the Healthcare sector and 99.41% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.84% higher than that of the company.
Herantis Pharma Oyj Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Herantis Pharma's current stock value. Our valuation model uses many indicators to compare Herantis Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Herantis Pharma competition to find correlations between indicators driving Herantis Pharma's intrinsic value. More Info.Herantis Pharma Oyj is rated below average in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Herantis Pharma's earnings, one of the primary drivers of an investment's value.Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Herantis Pink Sheet
If you are still planning to invest in Herantis Pharma Oyj check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Herantis Pharma's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |